TABLE 5.
Outcomes | Minimally-adjusted Model HR (95% CI)* |
P-value | Fully-adjusted Model HR (95% CI)† |
P-value | Baseline sign × time-updated signs interaction P-value† |
---|---|---|---|---|---|
Composite endpoint | |||||
Time-updated signs | 1.57 (1.38, 1.77) | <0.001 | 1.43 (1.26, 1.62) | <0.001 | 0.62 |
Baseline signs | 1.08 (0.96, 1.23) | 0.21 | 1.05 (0.92, 1.19) | 0.50 | |
Cardiovascular mortality | |||||
Time-updated signs | 1.53 (1.28, 1.84) | <0.001 | 1.43 (1.18, 1.72) | <0.001 | 0.46 |
Baseline signs | 0.96 (0.79, 1.17) | 0.70 | 0.95 (0.78, 1.16) | 0.64 | |
HF hospitalization | |||||
Time-updated signs | 1.71 (1.49, 1.97) | <0.001 | 1.55 (1.34, 1.79) | <0.001 | 0.82 |
Baseline signs | 1.09 (0.95, 1.26) | 0.25 | 1.04 (0.90, 1.21) | 0.59 | |
All cause mortality | |||||
Time-updated signs | 1.44 (1.25, 1.65) | <0.001 | 1.35 (1.17, 1.55) | <0.001 | 0.02 |
Baseline signs | 0.99 (0.85, 1.14) | 0.84 | 0.98 (0.84, 1.14) | 0.76 |
HF, heart failure; CI, confidence interval;
Baseline signs do not predict adverse events when simultaneously adjusted for time-updated signs of congestion.
Adjusted simultaneously for time-updated and baseline number of signs of congestion.
Additionally adjusted for New York Heart Association class, diabetes mellitus, serum creatinine, heart rate, age, white race, current smoking, atrial fibrillation, peripheral artery disease, ejection fraction, randomization arm, and sex.